Schedule 13G ownership disclosure
Aclaris Therapeutics Inc
Security class unavailable · CUSIP: 00461U105
Event date: 2023-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,372,601
- Percent of class
- 11.0500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-23-000018
- Form type
- SC 13G
- Filer
- Aclaris Therapeutics, Inc.
- CIK
- CIK 1557746
- Filed
- Apr 10, 2023
- Reporting period
- Mar 31, 2023
- Description
- Schedule 13G beneficial ownership